The Ensign Group, Inc. (ENSG) Cash Flow Statement

The consistent OCF/NI ratio above 1.0 across most quarters suggests that reported earnings are well-backed by cash generation, with non-cash charges like D&A and SBC providing a cushion. The Q1 2026 dip to 1.00 and Q1 2025 to 0.90 appear tied to seasonal working capital outflows, but the overall trend indicates high conversion quality. Investors should monitor whether the gap narrows as acquisition integration costs rise.

The trajectory shows a clear upward trend in FCF, with Q2 2026 FCF nearly triple the level of Q2 2024, driven by revenue growth and stable capex intensity. The Q4 2025 spike in capex (positive $190.5M) appears to be a data anomaly, likely a sale-leaseback or asset disposal, which temporarily inflated FCF. Excluding that, FCF margins have improved from low single digits to high single digits, suggesting the acquisition-heavy strategy is beginning to generate cash returns.

The low capex-to-revenue ratio, consistently below 5% except for the anomalous Q4 2025, suggests that Ensign's asset-light operating model requires minimal reinvestment relative to its revenue base. This is consistent with a strategy of acquiring facilities and leveraging existing infrastructure, rather than heavy greenfield development. The modest capex supports strong FCF conversion, but investors should watch for potential increases if the company shifts toward more development-oriented investments.

The negative working capital changes in Q1 quarters (2025 and 2026) suggest seasonal outflows, possibly due to incentive compensation or timing of receivables, while Q4 2025 saw a large positive inflow. This pattern is typical for healthcare providers with government payers, where collection cycles can be lumpy. The overall impact on annual cash flow appears neutral, but the volatility warrants monitoring for any deterioration in collection efficiency.

The company's capital deployment strategy appears focused on acquisitions, as evidenced by the $156.1M net acquisition outflow in Q4 2024, while also returning modest capital to shareholders. The low debt/equity ratio of 1.86% provides ample dry powder for future deals, and the consistent dividend, though small, signals confidence in cash flow stability. The buyback activity is minimal, suggesting management prioritizes reinvestment over repurchases.

The cumulative gap of approximately $340M between OCF and net income highlights the significant non-cash charges (D&A and SBC) that reduce reported earnings but not cash generation. This divergence suggests that Ensign's earnings quality is high, with cash flows providing a more accurate picture of economic performance. However, the gap may narrow if acquisition-related amortization increases or if working capital turns negative.